TECON BIOLOGY Co.LTD (SHE:002100)
China · Delayed Price · Currency is CNY 7.17
+0.02 (0.28%)
Aug 24, 2026, 3:04 PM CST
TECON BIOLOGY Co.LTD Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 2,831 | 2,081 | 3,102 | 2,822 | 3,320 | 3,424 |
Trading Asset Securities | 426.28 | 349.97 | 5.52 | 0.47 | 650.94 | - |
Cash & Short-Term Investments | 3,257 | 2,431 | 3,107 | 2,822 | 3,970 | 3,424 |
Cash Growth | -0.41% | -21.78% | 10.11% | -28.92% | 15.96% | 64.03% |
Accounts Receivable | 628.11 | 450.22 | 534.08 | 444.28 | 401.82 | 314.58 |
Other Receivables | 248.43 | 274.9 | 396.56 | 425.39 | 464.03 | 437.5 |
Receivables | 876.55 | 728.61 | 943.13 | 889.67 | 885.44 | 771.88 |
Inventory | 5,345 | 5,565 | 4,594 | 4,554 | 6,042 | 5,251 |
Prepaid Expenses | - | - | - | - | - | 5.37 |
Other Current Assets | 1,311 | 1,225 | 1,204 | 695.1 | 1,498 | 1,160 |
Total Current Assets | 10,789 | 9,950 | 9,848 | 8,961 | 12,396 | 10,612 |
Property, Plant & Equipment | 6,557 | 6,715 | 6,975 | 7,093 | 6,453 | 6,081 |
Long-Term Investments | 15.94 | 16.52 | 33.29 | 36.11 | 105.45 | 108.07 |
Goodwill | 165.82 | 165.82 | 165.82 | 178.48 | 22.24 | 22.24 |
Other Intangible Assets | 362.34 | 363.78 | 377.17 | 360.84 | 268.4 | 272.11 |
Long-Term Deferred Tax Assets | 115.6 | 112.25 | 99.14 | 72.18 | 39.54 | 16.06 |
Long-Term Deferred Charges | 27.97 | 29 | 26.48 | 31.05 | 30.83 | 26.17 |
Other Long-Term Assets | 9.23 | 39.17 | 38.22 | 19.34 | 46.9 | 1.28 |
Total Assets | 18,043 | 17,391 | 17,563 | 16,752 | 19,362 | 17,139 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 714.83 | 601.58 | 611.86 | 697.12 | 611.11 | 465.23 |
Accrued Expenses | 196.89 | 257.29 | 364.43 | 411.89 | 405.67 | 436.52 |
Short-Term Debt | 2,860 | 3,114 | 3,233 | 3,319 | 3,215 | 4,039 |
Current Portion of Long-Term Debt | 922.21 | 996.28 | 739.8 | 1,366 | 624.37 | 676.7 |
Current Portion of Leases | - | 69.75 | 126.1 | 122.77 | 102.31 | 64.85 |
Current Income Taxes Payable | 31.54 | 6.45 | 11.68 | 16.83 | 11.23 | 8.27 |
Current Unearned Revenue | 1,044 | 806.3 | 669.11 | 444.63 | 476.32 | 686.52 |
Other Current Liabilities | 834.49 | 643.55 | 738.56 | 708.94 | 762.53 | 594.67 |
Total Current Liabilities | 6,604 | 6,495 | 6,495 | 7,087 | 6,208 | 6,971 |
Long-Term Debt | 2,552 | 1,876 | 2,057 | 1,225 | 3,133 | 2,059 |
Long-Term Leases | 278.09 | 313.04 | 322.12 | 362.93 | 302.53 | 294.58 |
Long-Term Unearned Revenue | 150.43 | 152.94 | 144.58 | 143.29 | 87.51 | 81.02 |
Long-Term Deferred Tax Liabilities | 17.68 | 18.08 | 17.62 | 18.13 | 1.45 | 0.75 |
Other Long-Term Liabilities | 0.09 | 0.09 | 6.42 | - | - | - |
Total Liabilities | 9,602 | 8,854 | 9,043 | 8,837 | 9,733 | 9,406 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,365 | 1,365 | 1,365 | 1,365 | 1,354 | 1,354 |
Additional Paid-In Capital | 3,945 | 3,945 | 3,942 | 3,942 | 3,842 | 3,303 |
Retained Earnings | 1,404 | 1,567 | 1,657 | 1,052 | 2,713 | 2,447 |
Comprehensive Income & Other | 144.63 | 63.65 | 51.06 | 51.12 | 5.03 | -5.4 |
Total Common Equity | 6,859 | 6,941 | 7,016 | 6,411 | 7,915 | 7,098 |
Minority Interest | 1,583 | 1,595 | 1,504 | 1,504 | 1,715 | 634.88 |
Shareholders' Equity | 8,442 | 8,537 | 8,520 | 7,915 | 9,630 | 7,733 |
Total Liabilities & Equity | 18,043 | 17,391 | 17,563 | 16,752 | 19,362 | 17,139 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 6,611 | 6,368 | 6,479 | 6,396 | 7,377 | 7,133 |
Net Cash (Debt) | -3,354 | -3,938 | -3,371 | -3,574 | -3,406 | -3,709 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -2.38 | -2.80 | -2.45 | -2.65 | -2.55 | -3.38 |
Filing Date Shares Outstanding | 1,365 | 1,365 | 1,365 | 1,365 | 1,354 | 1,354 |
Total Common Shares Outstanding | 1,365 | 1,365 | 1,365 | 1,365 | 1,354 | 1,354 |
Working Capital | 4,186 | 3,455 | 3,353 | 1,874 | 6,188 | 3,641 |
Book Value Per Share | 5.02 | 5.08 | 5.14 | 4.70 | 5.84 | 5.24 |
Tangible Book Value | 6,331 | 6,412 | 6,473 | 5,871 | 7,625 | 6,803 |
Tangible Book Value Per Share | 4.64 | 4.70 | 4.74 | 4.30 | 5.63 | 5.03 |
Buildings | - | 5,369 | 5,237 | 4,664 | 4,183 | 3,541 |
Machinery | - | 4,146 | 3,992 | 3,499 | 3,206 | 2,626 |
Construction In Progress | - | 255.43 | 233.09 | 814.7 | 425.14 | 894.54 |